Osagie O. Imasogie is an entrepreneur and businessperson who founded 9 companies, which include: Phoenix IP Ventures LLC, Churchill Pharmaceuticals and Ilera Healthcare LLC and who has been at the head of 10 different companies. Currently, he holds the position of Chairman at Zelira Therapeutics Ltd., Chairman at Ilera Therapeutics LLC (a subsidiary of Zelira Therapeutics Ltd.), Chairman & Chief Executive Officer at Ibere Pharmaceuticals, Senior Managing Partner at Phoenix IP Ventures LLC (which he founded in 2010), Chairman of Ilera Healthcare LLC (which he founded in 2016) and Advisor at Ben Franklin Technology Partners. Mr. Imasogie is also Chairman at The University of Pennsylvania Law School, Attorney at Schnader Harrison Segal & Lewis LLP, Member of New York State Bar Association, Member of Wilson Council and Senior Managing Partner at Pipv Capital (he founded the company in 2004) and on the board of 9 other companies.
In the past he occupied the position of Chairman for Churchill Pharmaceuticals (he founded the company), EVP-Global Corporation Development at Dr. Reddy's Laboratories Ltd. and Chairman at Trigenesis Therapeutics, Inc. (a subsidiary of Dr. Reddy's Laboratories Ltd.), Founding Vice President at GSK Venture Fund, Chairman at iCeutica, Inc. (he founded the company), Chairman for Ception Therapeutics, Inc. (he founded the company in 2004), Chairman at Iroko Pharmaceuticals LLC (he founded the company), Partner-Corporate Finance at Pricewaterhouse & Co., VP & Director-Product Development Strategy at Smithkline Beckman Corp, VP, Director-Genetics & Discovery Venture at GlaxoSmithKline Research & Development, VP-International Sales & Marketing at DuPont Merck Pharmaceutical Co. and SVP-Business Development & General Counsel at Endo Pharmaceuticals, Inc. (he founded the company in 1997).
He received a graduate degree from London School of Economics & Political Science and a graduate degree from The University of Pennsylvania Law School.